Yüklüyor......
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
BACKGROUND: Chemotherapy resistance presents a difficult challenge in treating epithelial ovarian cancer patients, particularly when tumors exhibit resistance to multiple chemotherapeutic agents. A few studies have shown that elevated serum levels of the ovarian cancer biomarker HE4 correlate with t...
Kaydedildi:
| Yayımlandı: | J Ovarian Res |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869286/ https://ncbi.nlm.nih.gov/pubmed/27184254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0240-0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|